Skip to main content
. 2018 Aug 8;11(5):1225–1231. doi: 10.1016/j.tranon.2018.07.016

Figure 1.

Figure 1

Expression levels of SNHG1 and RMRP in plasma samples of 63 lung cancer patients and 33 cancer-free controls. (A) SNHG1 and RMRP displayed a higher plasma level in lung cancer patients vs. cancer-free controls (all P < .001). (B) The receiver operating characteristic curves of SNHG1 and RMRP produced an AUC of 0.90 and 0.80, respectively, in diagnosis of lung cancer.